Clinical Trial Update: Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating non-inferiority of a 12-valent pneumococcal conjugate vaccine in healthy Brazilian children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• 12-valent pneumococcal conjugate vaccine

Snippet

Sponsor: Maria de Lourdes de Sousa Maia, MD | Conditions: Pneumococcal Vaccines | Phase 3 | Status: UNKNOWN